FDA inspection
GEXPRO, a Division of REXEL USA Inc: FDA inspection ending Sep 23, 2024
FDA inspection 1252511 · No Action Indicated (NAI) · Menomonee Falls, WI
Key facts
| Inspection ID | 1252511 |
|---|---|
| Firm | GEXPRO, a Division of REXEL USA Inc |
| FEI number | 3007545404 |
| Address | W134n5450 Campbell Dr |
| City | Menomonee Falls |
| State | WI |
| ZIP | 53051 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 23, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data